ATE87007T1 - Fusionsprotein, enthaltend lymphotoxin. - Google Patents

Fusionsprotein, enthaltend lymphotoxin.

Info

Publication number
ATE87007T1
ATE87007T1 AT88904653T AT88904653T ATE87007T1 AT E87007 T1 ATE87007 T1 AT E87007T1 AT 88904653 T AT88904653 T AT 88904653T AT 88904653 T AT88904653 T AT 88904653T AT E87007 T1 ATE87007 T1 AT E87007T1
Authority
AT
Austria
Prior art keywords
protein
fusion protein
protein containing
lymphotoxin
ppralt
Prior art date
Application number
AT88904653T
Other languages
English (en)
Inventor
Tetsuzo Miki
Seishi Kato
Hiroshi Osada
Original Assignee
Sagami Chem Res
Central Glass Co Ltd
Hodogaya Chemical Co Ltd
Nissan Chemical Ind Ltd
Tosoh Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chem Res, Central Glass Co Ltd, Hodogaya Chemical Co Ltd, Nissan Chemical Ind Ltd, Tosoh Corp filed Critical Sagami Chem Res
Application granted granted Critical
Publication of ATE87007T1 publication Critical patent/ATE87007T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/525Tumour necrosis factor [TNF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/55Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88904653T 1987-05-29 1988-05-28 Fusionsprotein, enthaltend lymphotoxin. ATE87007T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13172687 1987-05-29
EP88904653A EP0317641B1 (de) 1987-05-29 1988-05-28 Fusionsprotein, enthaltend lymphotoxin
PCT/JP1988/000525 WO1988009343A1 (en) 1987-05-29 1988-05-28 Fused protein containing lymphotoxin

Publications (1)

Publication Number Publication Date
ATE87007T1 true ATE87007T1 (de) 1993-04-15

Family

ID=15064759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904653T ATE87007T1 (de) 1987-05-29 1988-05-28 Fusionsprotein, enthaltend lymphotoxin.

Country Status (6)

Country Link
US (1) US5095096A (de)
EP (1) EP0317641B1 (de)
JP (1) JPH082315B1 (de)
AT (1) ATE87007T1 (de)
DE (1) DE3879395T2 (de)
WO (1) WO1988009343A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004692A (en) * 1987-12-15 1991-04-02 Protein Design Labs, Inc. Cloning and expression of phosopholipase C genes
IE63847B1 (en) * 1989-05-05 1995-06-14 Res Dev Foundation A novel antibody delivery system for biological response modifiers
US6267964B1 (en) 1989-08-01 2001-07-31 Affibody Technology Sweden Ab Stabilized protein or peptide conjugates able to bond albumin having extended biological half-lives
SE509359C2 (sv) * 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US5314995A (en) * 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
US5273889A (en) * 1990-08-22 1993-12-28 University Of Saskatchewan Gamma-iterferon-leukotoxin gene fusions and uses thereof
US5238823A (en) * 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
US5594107A (en) * 1990-08-22 1997-01-14 University Of Saskatchewan Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
DK0546124T4 (da) * 1990-08-29 2003-05-19 Inst Genetics Llc Hæmatopoiese-stimulatorer med flere domæner
JPH05255393A (ja) * 1990-09-21 1993-10-05 Ishihara Sangyo Kaisha Ltd ポリペプチド
US5525491A (en) * 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
EP0965597A4 (de) * 1996-12-27 2003-01-08 Mochida Pharm Co Ltd Zellmembran-wirksame medikamente
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
JP2004535202A (ja) 2001-07-17 2004-11-25 リサーチ ディベロップメント ファンデーション アポトーシス促進性蛋白質を含む治療剤
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7495090B2 (en) 2002-05-23 2009-02-24 The Regents Of The University Of California Nucleic acids encoding chimeric CD154 polypeptides
EP2977055A1 (de) 2010-02-16 2016-01-27 Novo Nordisk A/S Faktor-viii-fusionsproteine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
SE462046C (sv) * 1982-08-23 1998-04-27 Pharmacia Biotech Ab Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
NZ212312A (en) * 1984-06-07 1988-09-29 John Richard Murphy Hybrid protein comprising fragments of diphtheria toxin and part of cell-specific ligand; and fused gene therefor
EP0196864A3 (de) * 1985-03-25 1988-03-23 Cetus Corporation Behandlung und Sekretion von rekombinanten Proteinen mittels alkalischer Phosphatase, dazu verwendbare DNA-Sequenzen und mittels dieser Sequenzen transformierte Zellen
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering

Also Published As

Publication number Publication date
DE3879395D1 (de) 1993-04-22
EP0317641A1 (de) 1989-05-31
US5095096A (en) 1992-03-10
EP0317641B1 (de) 1993-03-17
JPH082315B1 (de) 1996-01-17
WO1988009343A1 (en) 1988-12-01
DE3879395T2 (de) 1993-06-24
EP0317641A4 (en) 1991-07-24

Similar Documents

Publication Publication Date Title
DE3879395D1 (de) Fusionsprotein, enthaltend lymphotoxin.
ES2073081T3 (es) Proteinas de fusion a base de interleucina-2 e hirudina.
ATE140731T1 (de) Plasmidvektor mit pectatlyase-signalsequenz
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
ES8605040A1 (es) Procedimiento para preparar un polipeptido con actividad de hirudina
FI943563A0 (fi) Uusia biologisesti aktiivisia polypeptidejä, niiden valmistus ja niitä sisältävä farmaseuttinen koostumus
DE69534381D1 (de) Hämatopoietisches fusionsprotein multivariantes il-3 enthaltend
NO863806L (no) Arab promotorer og fremgangsmaate for fremstilling av polypeptider inkludert cecropiner, ved mikrobiologiske teknikker.
ES2072893T3 (es) Endoproteasa kex2 y procedimiento para su produccion.
SE8101005L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos humant interferon, dna och plasmider, som koderar for denna sekvens, mikroorganismer, som innehaller dessa genetiska informationer och forfaran...
NZ222856A (en) Equine interferon gamma (eq ifn alpha), dna sequences for its recombinant production and monoclonal antibodies thereto
KR900701819A (ko) 박테리아에서 폴리펩티드 번역 후 수식을 유도하는 선도 서열 및 그의 유전자
RU93045577A (ru) Слитные полипептиды
DK192189A (da) Polypeptid, fremgangsmaade til inhibering af fibrinogen, fremgangsmaade til rensning af et polypeptid, gen indeholdende rekombinante dna kodende for et polypeptid, vektor, cellekultur og fremgangsmaade til fremstilling af et cysteinrigt polypeptid
ATE154638T1 (de) Mutanten von interleukin-3
ATE170556T1 (de) Dna-sequenzen, vektoren und fusionspolypeptide zur erhöhung der sekretion gewünschter polypeptide von filamentösen fungi
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
SE8101004L (sv) Mikrobiologiskt framstelld polypeptid med samma aminosyrasekvens som hos humant interferon, dna och plasmider, som koderar for denna sekvens, mikroorganismer, som innehaller dessa genetiska informationer och forfarande
ES2000859A6 (es) Un metodo para producir un vector de expresion bacteriana para la expresion de proteinas de fusion
AU5695086A (en) A dna sequence
ES2005756A6 (es) Un metodo para liberar polipeptidos heterologos de proteinas de fusion.
NO883611L (no) Ekspresjonsplasmider som inneholder deo-promotere, og bakterielle verter som inneholder disse plasmidene.
JPS6460388A (en) Gene coding linked material of protein a-like substance fc bond region, recombinant plasmid containing said gene and transformant produced by using said recombinant plasmid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties